4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Tsarkakewa
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Sunan Sinadari | 4,6-Dichloro-2-Methylpyrimidine |
Makamantu | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
Lambar CAS | 1780-26-3 |
Lambar CAT | Saukewa: RF-PI687 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C5H4Cl2N2 |
Nauyin Kwayoyin Halitta | 163.00 |
Matsayin narkewa | 41.5 ~ 45.5 ℃ (lit.) |
Solubility (mai narkewa a ciki) | Methanol |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari ko Kashe-White Crystalline Foda |
Tsarkake / Hanyar Bincike | ≥99.5% (GC) |
Asara akan bushewa | ≤0.50% |
Ragowa akan Ignition | ≤0.20% |
Rashin Tsabtace Guda Daya | ≤0.50% |
Jimlar ƙazanta | ≤0.50% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Magunguna;Dasatinib/Moxonidine Intermediate |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Hanyar Tsari
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) ana amfani dashi a cikin haɗin magungunan magunguna da APIs.Shirye-shiryen Shirye-shiryen: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine sabon nau'in maganin hana hawan jini ne, wanda aka saba amfani dashi wajen maganin hauhawar jini mai mahimmanci.Idan aka kwatanta da tsofaffin magungunan antihypertensives na tsakiya, Moxonidine yana ɗaure tare da alaƙa da yawa ga imidazoline I1-receptor fiye da mai karɓar α2.Dasatinib shine mai hana oncogenic kinase inhibitor na baka, wanda zai iya toshe siginar haɓakar haɓakar ƙwayoyin cutar kansa, a cikin Mayu 2009, Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da siyar da dasatinib, An yi amfani da shi a asibiti don kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da kuma cututtukan da ke faruwa. myeloid leukemia (CML), ciki har da maganin cutar sankarar myeloid na yau da kullum wanda ke da juriya ko rashin haƙuri ga shirye-shiryen magani ciki har da imatinib mesylate., Philadelphia chromosome-positive m lymphoblastic leukemia (Ph + ALL) da kuma kula da marasa lafiya da ciwace-ciwacen ƙwayoyi.